Catheter Precision (VTAK) Return on Equity (2018 - 2026)

Catheter Precision (VTAK) has 9 years of Return on Equity data on file, last reported at 0.02% in Q1 2026.

• Quarterly Return on Equity changed 0.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (changed 0.0% YoY) and the FY2025 annual result came in at 0.02%, down 1.0% from the prior year.
• Return on Equity grew to 0.02% in Q1 2026 per VTAK's latest filing, from 0.02% in the prior quarter.
• Across five years, Return on Equity topped out at 0.0% in Q1 2024 and bottomed at 0.04% in Q1 2023.
• The 5-year median for Return on Equity is 0.02% (2025), against an average of 0.02%.
• The widest annual swing landed in 2023, when Return on Equity slipped 3 bps; it then advanced 4 bps in 2024.
• Tracing VTAK's Return on Equity over 5 years: stood at 0.02% in 2022, then tumbled by 33 bps to 0.03% in 2023, then surged by 59 bps to 0.01% in 2024, then sank by 72 bps to 0.02% in 2025, then surged by 32 bps to 0.02% in 2026.
• Per Business Quant, the three latest VTAK Return on Equity figures stand at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.03% (Q3 2025).

Peer Comparison